Can genes predict prostate cancer progression? new study seeks answers

NCT ID NCT05810467

First seen Feb 04, 2026 · Last updated Jun 22, 2026 · Updated 17 times

Summary

This study follows 200 men with low-risk prostate cancer who are on active surveillance (monitoring instead of immediate treatment). Researchers want to see if men with a higher genetic risk for prostate cancer are more likely to have their cancer progress over time. The goal is to better understand how genetic factors influence the disease, which could lead to more personalized care in the future.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Institute of Cancer Research and Royal Marsden Hospital

    RECRUITING

    Sutton, Surrey, SM2 5PT, United Kingdom

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • North Bristol NHS Trust

    NOT_YET_RECRUITING

    Bristol, BS10 5NB, United Kingdom

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The Royal Marsden Hospital

    RECRUITING

    London, SW3 6JJ, United Kingdom

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • The Royal Marsden Hospital

    RECRUITING

    Sutton, SM2 5PT, United Kingdom

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could help doctors better predict which men with low-risk prostate cancer are likely to see their cancer worsen, allowing more personalized monitoring.

What could go wrong

This is an observational study, not a treatment trial. It will not directly improve outcomes for participants, and results may take years to influence clinical practice.

Conditions

The condition(s) this trial relates to.

prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.